Shield Therapeutics PLC
SWB:1JS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of
Shield Therapeutics PLC (1JS) under the Base Case is 0.073 EUR per share.
Compared with the current market price of 0.034 EUR, the stock appears
Undervalued by 53% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Shield Therapeutics Does
Shield Therapeutics is a specialty pharmaceutical company focused on treating iron deficiency and iron deficiency anaemia. Its main product is an oral iron medicine designed for patients who cannot tolerate standard iron pills or who need a different way to replace iron. The company sells prescription medicine to healthcare providers and pharmacies, so the real customers are doctors, hospitals, and patients using the treatment under medical supervision.
- Headquarters
- United Kingdom UK
- Employees
- 63
- IPO date
- Feb 26, 2016
Balance Sheet
Continue 1JS Research
Decided on Shield Therapeutics? Get an email when 1JS reaches the price you’d buy at. Free with an account.
Other Shield Therapeutics listings
What is the Intrinsic Value of one 1JS stock?
The intrinsic value for
Shield Therapeutics PLC (1JS) under the Base Case is 0.073 EUR.
Is 1JS stock undervalued or overvalued?
Compared with the current market price of 0.034 EUR, the stock appears Undervalued by 53% .